![]() |
Patients with ovarian cancer usually have a poor prognosis. Photo Credit: National Cancer Institute |
A certain type of immunotherapy in which the body's T cells are programmed to attack cancer cells, called CAR-T cell therapy, is effective in ovarian cancer mice. It shows a study published in The Journal for Immuno Therapy of Cancer by researchers from Karolinska Institutet who hope the findings pave the way for a clinical trial to see how effective the treatment is for women with the disease.
This treatment exists today for patients with blood cancer and we now want to investigate whether we can use the method to treat ovarian cancer. Despite many improvements in treatment, women with ovarian cancer have continued to have a poor prognosis, says Isabelle Magalhaes, associate professor at Department of Oncology-Pathology at Karolinska Institutet and shared the last author of the study.